These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 38062011)

  • 1. Nuclear isoform of RAPH1 interacts with FOXQ1 to promote aggressiveness and radioresistance in breast cancer.
    Liu Q; Cao Y; Wei X; Dong H; Cui M; Guan S; Liu B; Wang X; Xing P
    Cell Death Dis; 2023 Dec; 14(12):803. PubMed ID: 38062011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TRIM32 promotes radioresistance by disrupting TC45-STAT3 interaction in triple-negative breast cancer.
    Ma Y; Zhang H; Chen C; Liu L; Ding T; Wang Y; Ma D; Ling X; Chen X; Li J; Guansheng ; Zhong ; Ru G; Zhang L; Tang J
    Oncogene; 2022 Mar; 41(11):1589-1599. PubMed ID: 35091679
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of STAT3 and Bcl-2 and reduction of reactive oxygen species (ROS) promote radioresistance in breast cancer and overcome of radioresistance with niclosamide.
    Lu L; Dong J; Wang L; Xia Q; Zhang D; Kim H; Yin T; Fan S; Shen Q
    Oncogene; 2018 Sep; 37(39):5292-5304. PubMed ID: 29855616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DDR2 coordinates EMT and metabolic reprogramming as a shared effector of FOXQ1 and SNAI1.
    Mitchell AV; Wu J; Meng F; Dong L; Block CJ; Song WM; Zhang B; Li J; Wu G
    Cancer Res Commun; 2022 Nov; 2(11):1388-1403. PubMed ID: 36713812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. STAT3 Targets
    Ma JH; Qi J; Lin SQ; Zhang CY; Liu FY; Xie WD; Li X
    Mol Cancer Res; 2019 Nov; 17(11):2184-2195. PubMed ID: 31427441
    [TBL] [Abstract][Full Text] [Related]  

  • 6. THOC2 and THOC5 Regulate Stemness and Radioresistance in Triple-Negative Breast Cancer.
    Bai X; Ni J; Beretov J; Wang S; Dong X; Graham P; Li Y
    Adv Sci (Weinh); 2021 Dec; 8(24):e2102658. PubMed ID: 34708581
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RNA-binding protein MSI2 isoforms expression and regulation in progression of triple-negative breast cancer.
    Li M; Li AQ; Zhou SL; Lv H; Wei P; Yang WT
    J Exp Clin Cancer Res; 2020 May; 39(1):92. PubMed ID: 32448269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CDK2-activated TRIM32 phosphorylation and nuclear translocation promotes radioresistance in triple-negative breast cancer.
    Tang J; Li J; Lian J; Huang Y; Zhang Y; Lu Y; Zhong G; Wang Y; Zhang Z; Bai X; Fang M; Wu L; Shen H; Wu J; Wang Y; Zhang L; Zhang H
    J Adv Res; 2024 Jul; 61():239-251. PubMed ID: 37734566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Luteolin suppresses epithelial-mesenchymal transition and migration of triple-negative breast cancer cells by inhibiting YAP/TAZ activity.
    Cao D; Zhu GY; Lu Y; Yang A; Chen D; Huang HJ; Peng SX; Chen LW; Li YW
    Biomed Pharmacother; 2020 Sep; 129():110462. PubMed ID: 32768952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Upregulation of MGP by HOXC8 promotes the proliferation, migration, and EMT processes of triple-negative breast cancer.
    Gong C; Zou J; Zhang M; Zhang J; Xu S; Zhu S; Yang M; Li D; Wang Y; Shi J; Li Y
    Mol Carcinog; 2019 Oct; 58(10):1863-1875. PubMed ID: 31264274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Triple-negative breast cancer-derived microvesicles transfer microRNA221 to the recipient cells and thereby promote epithelial-to-mesenchymal transition.
    Das K; Paul S; Singh A; Ghosh A; Roy A; Ansari SA; Prasad R; Mukherjee A; Sen P
    J Biol Chem; 2019 Sep; 294(37):13681-13696. PubMed ID: 31341019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Forkhead transcription factor foxq1 promotes epithelial-mesenchymal transition and breast cancer metastasis.
    Zhang H; Meng F; Liu G; Zhang B; Zhu J; Wu F; Ethier SP; Miller F; Wu G
    Cancer Res; 2011 Feb; 71(4):1292-301. PubMed ID: 21285253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FOXQ1 promotes gastric cancer metastasis through upregulation of Snail.
    Zhang J; Liu Y; Zhang J; Cui X; Li G; Wang J; Ren H; Zhang Y
    Oncol Rep; 2016 Jun; 35(6):3607-13. PubMed ID: 27109028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BUB1 regulates non-homologous end joining pathway to mediate radioresistance in triple-negative breast cancer.
    Sriramulu S; Thoidingjam S; Chen WM; Hassan O; Siddiqui F; Brown SL; Movsas B; Green MD; Davis AJ; Speers C; Walker E; Nyati S
    J Exp Clin Cancer Res; 2024 Jun; 43(1):163. PubMed ID: 38863037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FOXQ1 recruits the MLL complex to activate transcription of EMT and promote breast cancer metastasis.
    Mitchell AV; Wu L; James Block C; Zhang M; Hackett J; Craig DB; Chen W; Zhao Y; Zhang B; Dang Y; Zhang X; Zhang S; Wang C; Gibson H; Pile LA; Kidder B; Matherly L; Yang Z; Dou Y; Wu G
    Nat Commun; 2022 Nov; 13(1):6548. PubMed ID: 36319643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Obesity promotes radioresistance through SERPINE1-mediated aggressiveness and DNA repair of triple-negative breast cancer.
    Su YH; Wu YZ; Ann DK; Chen JL; Kuo CY
    Cell Death Dis; 2023 Jan; 14(1):53. PubMed ID: 36681663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FOXQ1 mediates the crosstalk between TGF-β and Wnt signaling pathways in the progression of colorectal cancer.
    Peng X; Luo Z; Kang Q; Deng D; Wang Q; Peng H; Wang S; Wei Z
    Cancer Biol Ther; 2015; 16(7):1099-109. PubMed ID: 25955104
    [TBL] [Abstract][Full Text] [Related]  

  • 18. VGLL4 interacts with STAT3 to function as a tumor suppressor in triple-negative breast cancer.
    Song H; Luo Q; Deng X; Ji C; Li D; Munankarmy A; Jian W; Zhao J; Fang L
    Exp Mol Med; 2019 Nov; 51(11):1-13. PubMed ID: 31748508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PRAME promotes epithelial-to-mesenchymal transition in triple negative breast cancer.
    Al-Khadairi G; Naik A; Thomas R; Al-Sulaiti B; Rizly S; Decock J
    J Transl Med; 2019 Jan; 17(1):9. PubMed ID: 30602372
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Calycosin inhibits triple-negative breast cancer progression through down-regulation of the novel estrogen receptor-α splice variant ER-α30-mediated PI3K/AKT signaling pathway.
    Li Y; Hu S; Chen Y; Zhang X; Gao H; Tian J; Chen J
    Phytomedicine; 2023 Sep; 118():154924. PubMed ID: 37393829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.